1. Home
  2. MGYR vs MXCT Comparison

MGYR vs MXCT Comparison

Compare MGYR & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$17.20

Market Cap

112.7M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.19

Market Cap

129.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
MXCT
Founded
1922
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.7M
129.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MGYR
MXCT
Price
$17.20
$1.19
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
3.6K
902.6K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
N/A
EPS
0.98
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
$18.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.00
$0.64
52 Week High
$20.00
$2.37

Technical Indicators

Market Signals
Indicator
MGYR
MXCT
Relative Strength Index (RSI) 65.58 61.43
Support Level $16.96 $1.08
Resistance Level $18.88 $1.30
Average True Range (ATR) 0.17 0.07
MACD 0.08 -0.01
Stochastic Oscillator 100.00 60.47

Price Performance

Historical Comparison
MGYR
MXCT

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: